DK173590B1 - Fremgangsmåde til fremstilling af et antiviralt polypeptid og at et dobbeltstrenget DNA, der omfatter en sekvens, der koder - Google Patents

Fremgangsmåde til fremstilling af et antiviralt polypeptid og at et dobbeltstrenget DNA, der omfatter en sekvens, der koder Download PDF

Info

Publication number
DK173590B1
DK173590B1 DK198104946A DK494681A DK173590B1 DK 173590 B1 DK173590 B1 DK 173590B1 DK 198104946 A DK198104946 A DK 198104946A DK 494681 A DK494681 A DK 494681A DK 173590 B1 DK173590 B1 DK 173590B1
Authority
DK
Denmark
Prior art keywords
leif
amino acids
polypeptide
amino acid
fragment
Prior art date
Application number
DK198104946A
Other languages
Danish (da)
English (en)
Other versions
DK494681A (da
Inventor
David Norman Van Goeddel
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/237,388 external-priority patent/US4414150A/en
Priority claimed from US06/305,657 external-priority patent/US4456748A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK494681A publication Critical patent/DK494681A/da
Application granted granted Critical
Publication of DK173590B1 publication Critical patent/DK173590B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK198104946A 1980-11-10 1981-11-09 Fremgangsmåde til fremstilling af et antiviralt polypeptid og at et dobbeltstrenget DNA, der omfatter en sekvens, der koder DK173590B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US20557980A 1980-11-10 1980-11-10
US20557980 1980-11-10
US06/237,388 US4414150A (en) 1980-11-10 1981-02-23 Hybrid human leukocyte interferons
US23738881 1981-02-23
US30565781 1981-09-25
US06/305,657 US4456748A (en) 1981-02-23 1981-09-25 Hybrid human leukocyte interferons

Publications (2)

Publication Number Publication Date
DK494681A DK494681A (da) 1982-05-11
DK173590B1 true DK173590B1 (da) 2001-04-02

Family

ID=27394813

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198104946A DK173590B1 (da) 1980-11-10 1981-11-09 Fremgangsmåde til fremstilling af et antiviralt polypeptid og at et dobbeltstrenget DNA, der omfatter en sekvens, der koder

Country Status (34)

Country Link
EP (1) EP0051873B1 (nl)
JP (1) JP2642291B2 (nl)
KR (1) KR920007439B1 (nl)
AT (1) ATE46718T1 (nl)
AU (1) AU555293B2 (nl)
BR (1) BR8107293A (nl)
CA (2) CA1212915A (nl)
CH (2) CH663032A5 (nl)
DE (2) DE3144469A1 (nl)
DK (1) DK173590B1 (nl)
DO (1) DOP1981004064A (nl)
DZ (1) DZ350A1 (nl)
ES (2) ES8302778A1 (nl)
FI (1) FI79550C (nl)
FR (1) FR2493867B1 (nl)
GB (1) GB2090258B (nl)
GR (1) GR81947B (nl)
HK (1) HK51685A (nl)
IE (1) IE51850B1 (nl)
IL (1) IL64243A (nl)
IT (1) IT1169276B (nl)
KE (1) KE3536A (nl)
LU (1) LU83745A1 (nl)
MC (1) MC1424A1 (nl)
MY (2) MY8700710A (nl)
NL (1) NL189092C (nl)
NO (1) NO165201C (nl)
NZ (1) NZ198906A (nl)
PH (1) PH18565A (nl)
PL (1) PL233748A1 (nl)
PT (1) PT73955B (nl)
SE (1) SE460539B (nl)
YU (1) YU46597B (nl)
ZW (1) ZW26981A1 (nl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH651308A5 (de) * 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
JPS58501543A (ja) * 1981-08-14 1983-09-16 エイ／エス　アルフレツド　ベンツオン ヒトインタ−フエロン蛋白とヒトインタ−フエロン蛋白に対する抗体に関する改良
EP0072541A3 (en) * 1981-08-14 1984-04-18 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
IT1167610B (it) * 1982-01-19 1987-05-13 Cetus Corp Interfreron ibrido multiclasse, composizione farmaceutica che lo contiene e procedimento di produzione
DE3220116A1 (de) * 1982-05-28 1983-12-01 Dr. Karl Thomae Gmbh, 7950 Biberach Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
CA1252046A (en) * 1982-11-04 1989-04-04 Martin J. Cline Methods for oncogenic detection
JPS60500574A (ja) * 1983-02-24 1985-04-25 インステイチユト　オルガニチエスコゴ　シンテザ　アカデミイ　ナウク　ラトビイスコイ　エスエスア−ル ヒト白血球インタ−フェロンｎ及び細菌細胞におけるその製造方法
GB8315980D0 (en) * 1983-06-10 1983-07-13 Biogen Nv Producing hybrid dna sequences
GB8317880D0 (en) * 1983-07-01 1983-08-03 Searle & Co Structure and synthesis of interferons
US4892743A (en) * 1983-12-21 1990-01-09 Schering Corporation Novel hybrid interferon species
EP0146903A3 (en) * 1983-12-19 1987-07-22 Schering Corporation Production of a vector encoding a novel hybrid interferon species
DE3409966A1 (de) * 1984-03-19 1985-09-26 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens
JPS6156199A (ja) * 1984-08-27 1986-03-20 Shionogi & Co Ltd 新規ヒトインタ−フエロンα類
EP0173935A1 (en) * 1984-08-31 1986-03-12 University Patents, Inc. Hybrid lymphoblastoid-leukocyte human interferons
DE3434345A1 (de) * 1984-09-19 1986-03-27 Hoechst Ag, 6230 Frankfurt Verwendung von (alpha)-interferonen zur bekaempfung von durchfaellen
DE3685044D1 (de) * 1985-02-01 1992-06-04 Ici Plc Analoge interferon-polypeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4885166A (en) * 1985-06-11 1989-12-05 Ciba-Geigy Corporation Hybrid interferons
WO1987002037A1 (en) * 1985-09-26 1987-04-09 Genetics Institute, Inc. Pulmonary surfactant proteins
US4806347A (en) * 1985-12-11 1989-02-21 Schering Corporation Interferon combinations
EP0490233A1 (de) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex
EP0331635A3 (en) * 1988-02-29 1990-02-28 The Board of Regents of the University of Texas System Preparations for treating bladder cancer
US5372808A (en) † 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
GB2273931A (en) * 1992-09-28 1994-07-06 Unilever Plc Mutant polypeptides
EP0830368A1 (en) 1995-06-07 1998-03-25 Genta Incorporated Novel carbamate-based cationic lipids
TW442492B (en) * 1995-07-26 2001-06-23 Novartis Ag Process for the enrichment of interferon
FR2823220B1 (fr) 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
US7314613B2 (en) 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
AU2005245918A1 (en) 2004-05-19 2005-12-01 F. Hoffmann-La Roche Ag Interferon-alpha polypeptides and conjugates
AU2006299901A1 (en) 2005-05-18 2007-04-19 Maxygen, Inc. Evolved interferon-alpha polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT72322B (en) * 1980-01-08 1982-09-23 Biogen Nv Process for preparation of recombinant dna molecules and of polipeptides similar to human interferon

Also Published As

Publication number Publication date
IL64243A0 (en) 1982-02-28
PT73955A (en) 1981-12-01
NO813785L (no) 1982-05-11
CH663032A5 (de) 1987-11-13
ES506955A0 (es) 1983-02-01
KE3536A (en) 1985-06-07
JP2642291B2 (ja) 1997-08-20
MC1424A1 (fr) 1982-10-18
PH18565A (en) 1985-08-09
SE460539B (sv) 1989-10-23
EP0051873A3 (en) 1982-09-22
NO165201B (no) 1990-10-01
JPH07308191A (ja) 1995-11-28
GB2090258B (en) 1984-05-02
FI813539L (fi) 1982-05-11
AU7730481A (en) 1982-05-20
ZW26981A1 (en) 1982-06-02
LU83745A1 (de) 1983-09-01
SE8106641L (sv) 1982-06-24
BR8107293A (pt) 1982-08-03
KR830007825A (ko) 1983-11-07
CH660743A5 (de) 1987-06-15
NL189092C (nl) 1993-01-04
YU265681A (en) 1984-08-31
CA1212915A (en) 1986-10-21
FI79550C (fi) 1990-01-10
ATE46718T1 (de) 1989-10-15
DZ350A1 (fr) 2004-09-13
FR2493867B1 (fr) 1986-06-27
GR81947B (nl) 1984-12-12
MY8700710A (en) 1987-12-31
MY8800066A (en) 1988-12-31
IT1169276B (it) 1987-05-27
IE812622L (en) 1982-05-10
IT8124967A0 (it) 1981-11-10
YU46597B (sh) 1994-01-20
KR920007439B1 (ko) 1992-09-01
ES8304200A1 (es) 1983-03-01
HK51685A (en) 1985-07-12
DK494681A (da) 1982-05-11
EP0051873B1 (en) 1989-09-27
NZ198906A (en) 1985-12-13
ES512354A0 (es) 1983-03-01
CA1277616C (en) 1990-12-11
NL8105078A (nl) 1982-06-01
NO165201C (no) 1991-01-16
IE51850B1 (en) 1987-04-15
DOP1981004064A (es) 1988-03-16
AU555293B2 (en) 1986-09-18
NL189092B (nl) 1992-08-03
DE3177106D1 (en) 1989-11-02
DE3144469A1 (de) 1982-09-02
IL64243A (en) 1985-11-29
FR2493867A1 (fr) 1982-05-14
FI79550B (fi) 1989-09-29
ES8302778A1 (es) 1983-02-01
EP0051873A2 (en) 1982-05-19
PL233748A1 (en) 1983-07-18
GB2090258A (en) 1982-07-07
PT73955B (en) 1983-11-23

Similar Documents

Publication Publication Date Title
DK173590B1 (da) Fremgangsmåde til fremstilling af et antiviralt polypeptid og at et dobbeltstrenget DNA, der omfatter en sekvens, der koder
US4456748A (en) Hybrid human leukocyte interferons
US4678751A (en) Hybrid human leukocyte interferons
DK173543B1 (da) Modent humant leukocytinterferon; en bakterie, der kan producere et sådant interferon, og en fremgangsmåde til fremstilling
DK170236B1 (da) Rekombinante DNA-molekyler, fremgangsmåde til fremstilling af et polypeptid af IFN-alfa typen og fremgangsmåde til udvælgelse af DNA-sekvenser, der koder for polypeptider af IFN-alfa typen
HU193512B (en) Process for preparing hybride interferones from human erythrocytes
KR860001558B1 (ko) 인터페론의 제조방법
NO813248L (no) Fremstilling av human-fibroblast-interferon.
HU202921B (en) Process for producing coding dns for human tumor necrosis factor the corresponding polypeptide with utilizing them and pharmaceutical compositions containing this polypeptide as active component
NO831041L (no) Nytt dna og fremgangsmaate for fremstilling derav.
SK278336B6 (en) Dna sequences, recombinant dna molecules and processes for producing swing growth hormone-like polypeptides
JPS6363199B2 (nl)
CA1338900C (en) Escherichia coli plasmid vector with lipoprotein promoter and modified shine-dalgarno sequence
FR2481316A1 (fr) Technique a adn de recombinant pour la preparation d'une proteine ressemblant a l'interferon humain
JPH064673B2 (ja) ハイブリド型ヒト白血球インタフエロン
KR910009901B1 (ko) 하이브리드 인간 백혈구 인터페론
SU1144376A1 (ru) Рекомбинатные плазмиды- @ - @ ,кодирующие синтез лейкоцитарного интерферона типа @ - @ человека, и штаммы @ @ / @ - @ - @ -продуценты лейкоцитарного интерферона типа @ -F человека
NO165555B (no) Kunstig hybrid humant leukocytt-interferon-kodende dna-sekvens.
FI82714C (fi) Foerfarande foer framstaellning av en transformerad stam av e.coli, som foermaor expressera ett humant moget leukocytinterferon.
GB2112395A (en) Recombinant cloning vector
NO164664B (no) Rekombinante dna-molekyler som omfatter en dna-sekvens som koder for et polypeptid av interferon alpha (ifn-alfa) type.
NO871590L (no) Mikrobiell ekspresjonsbaerer.
CS273182B2 (en) Method of expressive vector production capable to give mature human leucocytic interferon in transformed strain of escherichia coli by means of expression
IL63197A (en) Intraferons for mature human oocytes, their preparation and preparations containing them